drugset / Trial / NCT00942435

A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

NCT00942435

Phase 3 Completed 156 enrolled Astellas Pharma Inc
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of the study is to evaluate the efficacy and safety of the oral dose of YM150 for prevention of venous thromboembolism (VTE) in patients undergoing major abdominal surgery.

Timeline

Start
2009-06
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject darexaban Small molecule 15 mg Oral